These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11548096

  • 1. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H, Robinson G, Hanlon C, Hailwood C, Massarotto A.
    N Z Med J; 2001 Jul 27; 114(1136):324-6. PubMed ID: 11548096
    [Abstract] [Full Text] [Related]

  • 2. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
    Ramasamy P, Lintzeris N, Sutton Y, Taylor H, Day CA, Haber PS.
    Addiction; 2010 Feb 27; 105(2):329-34. PubMed ID: 20078489
    [Abstract] [Full Text] [Related]

  • 3. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W, Stanley J, Langton D, Kelly Y, Bury G.
    Eur J Gen Pract; 2007 Feb 27; 13(1):5-12. PubMed ID: 17366287
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R, Byrne A, Amin J, Dore GJ.
    J Gastroenterol Hepatol; 2005 Jul 27; 20(7):1082-6. PubMed ID: 15955218
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S, Linkins RW, Natephisarnwanish V, Levine WC, Maneesinthu K, Lolekha R, Tappero JW, Trirat N, Muktier S, Chancharastong P, Fox K, Donchalermpak S, Vitek C, Supawitkul S.
    Addiction; 2008 Oct 27; 103(10):1687-95. PubMed ID: 18705685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R, Miller J, Lungley S, Baker M.
    N Z Med J; 1998 Feb 27; 111(1060):50-3. PubMed ID: 9539916
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z, Gorisek JR, Poljak M, Pisec A.
    Wien Klin Wochenschr; 2004 Feb 27; 116 Suppl 2():5-7. PubMed ID: 15506302
    [Abstract] [Full Text] [Related]

  • 10. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L, Chant K, Jalaludin B, Sargent P.
    J Gastroenterol Hepatol; 2004 Oct 27; 19(10):1114-20. PubMed ID: 15377287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B vaccination and injecting drug users.
    Budd J, Robertson R, Elton R.
    Br J Gen Pract; 2004 Jun 27; 54(503):444-7. PubMed ID: 15186567
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.
    Isr Med Assoc J; 2008 Nov 27; 10(11):775-8. PubMed ID: 19070285
    [Abstract] [Full Text] [Related]

  • 14. Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Crofts N, Nigro L, Oman K, Stevenson E, Sherman J.
    Addiction; 1997 Aug 27; 92(8):999-1005. PubMed ID: 9376782
    [Abstract] [Full Text] [Related]

  • 15. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G, Bird R, O'Connor P, Bevin T, Loan R, Schroder M, McGrath R, Weatherall M, Moriarty H, Robinson G.
    Drug Alcohol Rev; 2010 Jan 27; 29(1):41-6. PubMed ID: 20078681
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatitis vaccination among drug users.
    Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais DC, Lechi A.
    Vaccine; 2006 Apr 05; 24(15):2702-9. PubMed ID: 16436307
    [Abstract] [Full Text] [Related]

  • 18. What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?
    Sheerin IG, Green FT, Sellman JD.
    Drug Alcohol Rev; 2004 Sep 05; 23(3):261-72. PubMed ID: 15370005
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Carballo E, Barrio E.
    Hepatogastroenterology; 2003 Sep 05; 50(54):2093-7. PubMed ID: 14696471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.